Skip to content
akaturk Academic measurement
Search

Article detail · 2021 · article

Protein domain-based prediction of drug/compound\u2013target interactions and experimental validation on LIM kinases

ISSN1553-7358
YÖKSİS OpenAlex Open access · gold
Year2021
Citations24OpenAlex
Citations15Semantic Scholar
Percentile%89.7
FWCI2.271.00 = world average
Scopus (SJR)Q1
WoS (JCR)Q1

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venuePLOS Computational Biology
  • Catalog match (ISSN)PLOS Computational Biology
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

Predictive approaches such as virtual screening have been used in drug discovery with the objective of reducing developmental time and costs. Current machine learning and network-based approaches have issues related to generalization, usability, or model interpretability, especially due to the complexity of target proteins' structure/function, and bias in system training datasets. Here, we propose a new method "DRUIDom" (DRUg Interacting Domain prediction) to identify bio-interactions between drug candidate compounds and targets by utilizing the domain modularity of proteins, to overcome problems associated with current approaches. DRUIDom is composed of two methodological steps. First, ligands/compounds are statistically mapped to structural domains of their target proteins, with the aim of identifying their interactions. As such, other proteins containing the same mapped domain or domain pair become new candidate targets for the corresponding compounds. Next, a million-scale dataset of small molecule compounds, including those mapped to domains in the previous step, are clustered based on their molecular similarities, and their domain associations are propagated to other compounds within the same clusters. Experimentally verified bioactivity data points, obtained from public databases, are meticulously filtered to construct datasets of active/interacting and inactive/non-interacting drug/compound-target pairs (~2.9M data points), and used as training data for calculating parameters of compound-domain mappings, which led to 27,032 high-confidence associations between 250 domains and 8,165 compounds, and a finalized output of ~5 million new compound-protein interactions. DRUIDom is experimentally validated by syntheses and bioactivity analyses of compounds predicted to target LIM-kinase proteins, which play critical roles in the regulation of cell motility, cell cycle progression, and differentiation through actin filament dynamics. We showed that LIMK-inhibitor-2 and its derivatives significantly block the cancer cell migration through inhibition of LIMK phosphorylation and the downstream protein cofilin. One of the derivative compounds (LIMKi-2d) was identified as a promising candidate due to its action on resistant Mahlavu liver cancer cells. The results demonstrated that DRUIDom can be exploited to identify drug candidate compounds for intended targets and to predict new target proteins based on the defined compound-domain relationships. Datasets, results, and the source code of DRUIDom are fully-available at: https://github.com/cansyl/DRUIDom.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

24citationsOpenAlex · cited_by_count (cache / database)

8 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2022 Learning functional properties of proteins with language modelsCitations 229 · OpenAlex
  2. 2022 Learning functional properties of proteins with language modelsCitations 229 · OpenAlex
  3. 2022 Learning functional properties of proteins with language modelsCitations 228 · OpenAlex
  4. 2023 How to approach machine learning-based prediction of drug/compound–target interactionsCitations 44 · OpenAlex
  5. 2022 Machine learning-based prediction of drug approvals using molecular, physicochemical, clinical trial, and patent-related featuresCitations 13 · OpenAlex
  6. 2022 SLPred: a multi-view subcellular localization prediction tool for multi-location human proteinsCitations 8 · OpenAlex
  7. 2022 SLPred: a multi-view subcellular localization prediction tool for multi-location human proteinsCitations 8 · OpenAlex
  8. 2023 ASCARIS: Positional feature annotation and protein structure-based representation of single amino acid variationsCitations 1 · OpenAlex

Authors

8
  1. TUNCA DOĞAN HACETTEPE ÜNİVERSİTESİ 1
  2. ECE AKHAN GÜZELCAN 2
  3. Marcus Baumann 3
  4. Altay Koyaş 4
  5. Heval Atas 5
  6. Ian Baxendale 6
  7. Maria Martin 7
  8. RENGÜL ATALAY 8